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Abstract: Patients with rheumatoid arthritis (RA) are prone to depression due to several fac-
tors related to their RA, including chronic and persistent pain, functional disability, economic 
constraints, and the side effects of RA medication. Previous Iranian studies showed conflicting 
and inconclusive findings regarding the prevalence of depression among RA patients. There-
fore, this systematic review and meta-analysis was conducted to estimate the true prevalence 
of depression in Iranian patients with RA. Search for eligible articles was performed using the 
keywords of depression, depressive disorder, dysthymic disorder, major depressive disorder, 
RA, and Iran, and their possible combinations in the following databases: Scientific Informa-
tion Database, MagIran, Web of Science/ISI, PubMed, and Scopus. The search was restricted to 
articles published in Persian and English languages. The meta-analysis was performed using the 
random effects model, and the data were analyzed using the STATA software version 12. Overall, 
six articles were selected; the overall prevalence of depression among the Iranian patients with 
RA was 65.58% (95% CI: 56.53%–74.62%). There were no significant relationships between 
the prevalence of depression and articles’ methodological quality and year of publication, par-
ticipants’ age, sample size, and duration of disease. More than half of RA patients suffer from 
depression. The overlap between the physical symptoms of RA and depression in this group of 
patients makes it difficult to correctly diagnose depression; therefore, initiative and efforts are 
required to improve the identification of early depression symptoms in RA patients in order to 
effectively manage their depression.
Keywords: depression, Iran, meta-analysis, prevalence, rheumatoid arthritis
Introduction
Rheumatoid arthritis (RA) is a systemic, chronic, and inflammatory disease that affects 
0.5%–1% of the world’s population.1 This painful and progressive disorder causes 
systemic disability and has no known treatment. Pharmacotherapies are only intended 
to reduce pain and inflammation, delay joint erosion, and maintain patient’s normal 
functioning.2 While the etiology of the disease is unclear, genetic, infectious, hormonal, 
and environmental factors may play a role in RA.3 The unpredictable courses of the 
illness and pain affect all the aspects of the patient’s life, such as social relationships, 
family life, and psychological well-being.4,5 Due to the different disease periods, patients 
with RA can hardly manage their daily life and disease process.5,6
Cohort studies have shown that the prevalence of depression is higher in patients 
with RA than in healthy subjects.7,8 Other cross-sectional studies have also shown that 
depression is more prevalent in patients with RA that in those with diabetes, cancer, 
or Parkinson’s disease.4,6,9–11
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Several factors that are related to RA could make this 
group of patients vulnerable to depression, including continu-
ous pain, functional disability, inability to work, economic 
constraints, and the side effects of RA medication.11 Further-
more, depression in this group of patients may be caused by 
the interaction among clinical, biological, psychological, 
and demographic factors.10 Depression in these patients is 
associated with fatigue, reduction of quality of life, increased 
inability and costs of treatment, and reduced compliance with 
the therapeutic regimen.12–15 Depression not only affects the 
effective management of RA but also impacts the effective 
management of other comorbid conditions that are often 
associated with RA, such as cardiovascular diseases, infec-
tion, and cancer.16,17 These patients are always concerned 
about joint deformity, impaired functioning, and inability 
to do daily activities, and this constant worry can increase 
the likelihood of several negative outcomes, such as losing 
one’s job, early retirement, and shorter working hours, hence, 
leading to a higher possibility of depression.3 Given the 
well-recognized, substantial negative impact of depression 
on patients’ quality of life, adherence to therapeutic regimen, 
and its association with suicidal thoughts, early identification 
and effective treatment of depression in patients with RA 
is necessary.18 This requires accurate statistical description 
of the prevalence of RA as it would help in planning and 
developing methods for better diagnosis and management of 
depression. Therefore, this study was designed to estimate 
the prevalence of depression in Iranian patients with RA.
Methods
The screening and selection process was carried out in accor-
dance with the PRISMA statement.19
Search strategy
In this systematic review and meta-analytic study, published 
articles in Persian and English languages in domestic and 
international journals were searched for in various databases 
(Scientific Information Database, MagIran, Web of Science/
ISI, PubMed [including Medline], and Scopus) from incep-
tion until February 2018. Search keywords were depression, 
depressive disorder, dysthymic disorder, major depressive 
disorder, RA, and Iran. The references of the identified 
articles were also accessed as the backtracking method to 
retrieve more articles.
Selection of studies and data extraction
All observational (noninterventional) articles reporting the 
prevalence of depression in Iranian patients with RA were 
eligible. The exclusion criteria included nonrelevant articles, 
case reports, interventional studies, repeated studies, and lack 
of access to the full text of articles. To reduce bias, the search 
process was performed independently by two researchers, 
and the disagreements between them were resolved through 
discussions. In the next step, the articles’ information includ-
ing the name of the first author, year of publication, place 
of study, sample size, type of instrument used, mean age of 
participants, duration of the disease, and the prevalence of 
depression were extracted and recorded on a specific form.
Quality assessment
The methodological quality of the selected articles was 
evaluated using a tool assessing five aspects: study plan, 
comparison groups, characteristics of the samples, sample 
size, and data collection tools. Each aspect was rated 0–3, 
and a higher score indicated a higher methodological qual-
ity20–22 (Table S1).
Statistical analyses
Since the prevalence rate has a binomial distribution, the vari-
ance of prevalence was calculated using the binomial distribu-
tion variance formula. Also, the weighted mean was used to 
combine the prevalence rates reported by different studies. To 
evaluate the heterogeneity between the selected studies, the 
Cochran’s Q test and the I2 statistic were used. Heterogeneity 
was classified into three categories of <25% (low heteroge-
neity), 25%–75% (moderate heterogeneity), and over 75% 
(high heterogeneity). According to the level of heterogeneity 
between the selected studies (89.3%) and the significance of 
I2 statistic (P<0.0001), the random effects model was used 
to combine the prevalence rates reported by the studies and 
estimate the total prevalence rate. The meta-regression was 
used to examine the relationship between the prevalence of 
depression with year of study, participants’ mean age, duration 
of disease, and sample size. The subgroup analysis was used 
to estimate the prevalence of depression among RA patients 
in different regions of Iran. Egger’s test and a Funnel plot were 
used to test the publication bias. The sensitivity analysis was 
performed through removing articles step by step. The data 
were analyzed using the STATA software v.12.
Registration
The study has been registered in the international prospec-
tive register of systematic review (PROSPERO) as number 
CRD42018100573. This study was a systematic review and 
meta-analysis of published studies, so it was not necessary 
to obtain an ethics approval or informed consent.
 
O
pe
n 
Ac
ce
ss
 R
he
um
at
ol
og
y:
 R
es
ea
rc
h 
an
d 
Re
vie
ws
 d
ow
nl
oa
de
d 
fro
m
 h
ttp
s:
//w
ww
.d
ov
ep
re
ss
.c
om
/ b
y 
13
0.
15
9.
82
.8
8 
on
 1
3-
Fe
b-
20
19
Fo
r p
er
so
na
l u
se
 o
nl
y.
Powered by TCPDF (www.tcpdf.org)
Open Access Rheumatology: Research and Reviews 2019:11 submit your manuscript | www.dovepress.com
Dovepress 
Dovepress
55
Jamshidi et al
Results
Of the 331 identified articles, a total of 6 articles were 
selected according to the inclusion criteria for the final 
analysis (Figure 1).
The overall sample size was 1,046 individuals within 
an average of 175 participants in each study. The largest 
and lowest sample sizes were for the studies of Jamshidi 
et al and Ghoreishi et al, respectively.23,24 The highest and 
lowest prevalence rates of depression were for the studies 
of Atapoor et al and Arman et al, respectively.25,26 In terms 
of methodological quality, all articles were in the moderate 
level. The general profile of selected studies for meta-analysis 
is reported in Table 1.
The overall prevalence of depression in patients with RA 
was 65.58 (95% CI: 56.53%–74.62%) (Figure 2).
The prevalence of depression in patients with RA was 
65.51% (95% CI: 54.88%–76.14%) using the Beck Depres-
sion Inventory and 66.00% (95% CI: 56.72%–75.28%) using 
the Hospital Anxiety and Depression Scale. The six final 
Figure 1 Screening process and selection of articles for meta-analysis according to the PRISMA statement.
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articles that had been screened and examined according to 
the PRISMA statement were assessed in terms of sensitivity. 
It was found that the overall estimate of the prevalence of 
depression was not changed by removing each of the studies. 
To investigate whether all articles on depression in Iranian 
patients with RA were included in the study, a bias diagram 
was drawn. Based on the Egger’s regression test, publication 
bias was not significant (P=0.76; Figure 3).
The results by the study language showed that the preva-
lence of depression in the Persian articles (72.28%; 95% 
CI: 51.31%–93.25%) was higher than those in the English 
articles (62.09%; 95% CI: 52.60%–71.57%). The results of 
single-variable meta-analysis showed that the methodological 
quality of the articles (P=0.88), participants’ age (P=0.77), 
sample size (P=0.54), and duration of disease (P=0.71) had 
no significant relationships with the prevalence of depression. 
An increase in the year of publication led to a downward trend 
in the prevalence of depression, which was not statistically 
significant (P=0.09; Figure 4).
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Table 1 Characteristics of the selected articles for meta-analysis
First author Year Sample 
size
City Tool Mean age, 
years
Length of 
disease
Quality 
score
Prevalence 
(%)
Jamshidi et al23 2016 414 Tehran BDI 45±11.6 5.5±5 5 63.6
Ghoreishi et al24 2016 81 Kashan BDI   5 72.2
Arman et al26 2016 171 Kermanshah BDI 45±11.2  6 47.7
Rezaei et al1 2014 100 Isfahan HADS   7 66
Ghorbanshiroudi et al27 2013 180 Rasht BDI 50.6±12.4 8.6±6.4 8 61.6
Atapoor et al 25 2002 100 Kerman BDI  6±6.5 7 83
Abbreviations: BDI, Beck Depression Inventory; HADS,  Hospital Anxiety and Depression Scale.
Figure 3 Publication bias in the selected studies.
Note: The circles show the weight of each study.
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Figure 2 Overall prevalence of depressive symptoms among patients with rheumatoid arthritis.
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Figure 4 Prevalence of depression in patients with rheumatoid arthritis in terms 
of publication year.
Note: Circles show the weight of each study.
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Discussion
A review of the literature showed that 47%–83% of the Ira-
nian patients with RA suffer from depression. These were 
different from the prevalence rates reported in other countries, 
such as 41.5% in Turkey and 71.5% in Pakistan.4,28 The study 
results also indicated that depression was more prevalent in 
patients with RA (65.5%) than the other chronic diseases, 
such as hemodialysis (62%), type II diabetes (54.8%), and 
cardiovascular diseases (47%).3,29–31
In this regard, it is important to note that in the Asian 
culture, depression is considered a kind of stigma, which is 
rarely expressed by patients explicitly; therefore, most cases 
are not diagnosed and treated. But in the Western culture, 
it is easy to describe this condition.7,32 Given the overlap 
between RA symptoms and depression, it may be difficult 
to diagnose depression in RA patients.33 Various studies 
suggested a high prevalence of depression in patients with 
RA.28–34 A meta-analysis of 12 studies showed the higher 
prevalence of depression in patients with RA than healthy 
subjects.35 Exposure to chronic mood disorders disrupts the 
hypothalamus–pituitary–adrenal axis, therefore, increasing 
the glucocorticoid release and the activity of the sympathetic 
system and decreasing the activity of the parasympathetic 
branches of the autonomic nervous system. Therefore, it ulti-
mately causes changes in inflammatory parameters and the 
progression of autoimmune diseases. The results of a 14-year 
cohort study showed that the risk of depression in patients 
with RA was 70% higher than in healthy individuals.36 About 
one-third of patients with RA lose their ability to work within 
3 years of diagnosis and are incapable of doing their daily 
routine, which imposes a large financial burden on patients, 
families, and health care systems.7 Due to the inability to 
perform daily life activities and experiencing chronic pain, 
they may live in poor economic conditions that increases 
the possibility of experiencing depression. Another impor-
tant factor for patients with RA is perceived social support. 
Patients with high levels of social support are less likely to 
have depression.37 According to the studies conducted in Iran, 
due to changes in cultural and social conditions, patients with 
chronic diseases may not have much social support, which 
can be associated with depression.38 Moreover, it has been 
reported that perceived social support was the most important 
predictor of depression and anxiety among patients with RA 
after controlling demographic variables.34
The results of the current study showed that there was 
no relationship between methodological quality, mean age 
of the participants, sample size, duration of the disease, and 
the prevalence of depression. With the increase of  publication 
years, the prevalence of depression showed a downward 
trend, which was not significant. This can be attributed to 
medical advances in identifying and controlling the disease. 
Another finding was that there was an inverse association 
between the age of participants and the prevalence of depres-
sion in patients with RA.39 The prevalence of depression in 
the studies published in English was lower than that in the 
Persian articles; this may be attributed to the higher quality 
of English journals and the fact that the articles published in 
these journals undergo more in-depth evaluations.
Some of the articles had not reported their full results; 
therefore, the lack of accurate and comprehensive reports in 
some of the analyzed studies constituted one of the limita-
tions of our meta-analysis. A comprehensive and up-to-date 
presentation of the prevalence of depression in patients with 
RA is one of the strengths of our meta-analysis. Overall, the 
findings of this study showed that more than half of patients 
with RA had depression symptoms. One of the most impor-
tant limitations of this study was that some selected articles 
had not provided all the required information.
Given the overlap between the depression and RA 
symptoms, it is more difficult to diagnose depression in RA 
patients. Depression as an underlying illness, along with 
persistent pain, disability, and economic constraints, leads 
to a decrease in the patients’ quality of life and reduces the 
patient’s adherence to the therapeutic regimen. Informing 
health care providers and policy makers about the prevalence 
of depression in patients with RA can help design programs 
and initiate interventions useful in better diagnosis and effec-
tive management of depression in this group of patients. 
Future studies are suggested to use validated screening tools 
to diagnose those patients with RA who are at risk of develop-
ing depression, so that their condition can be controlled, and 
effective and holistic interventions can be provided for them.
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Table S1 Criteria for rating the methodological quality of included articles
Study parameters Rating Criteria
Study design 3 Longitudinal prospective design
2 Retrospective or mixed design
1 Cross-sectional design
0 Survey or was not reported
Participants and 
recruitment
3 1) Description of the population, 2) eligibility criteria for participants, 3) precise details of the recruitment 
process, 4) accounted for the numbers recruited, and 5) lost to follow-up
2 Minimal description of at least four criteria
1 Two criteria missing
0 More than two criteria missing
Comparison group 3 Healthy, age-appropriate comparison
2 Reference sample
1 Other comparison group
0 No comparison group
Number of participants 3 N >100
2 N=50100
1 N<50
0 Did not report
Instruments 3 3V\FKRPHWULFDOO\VRXQGUHSRUWRIJHQHULFRUVSHFLÀFUHVLOLHQFHPHDVXUHV
2 3V\FKRPHWULFDOO\VRXQGUHSRUWRIJHQHULFDQGVSHFLÀFUHVLOLHQFHPHDVXUHV
1 6HOIUHSRUWJHQHULFRUVSHFLÀFUHVLOLHQFHPHDVXUHVZLWKVRPHSV\FKRPHWULFGDWD
0 Investigator constructed clinical rating of resilience or resilience domains with no psychometric properties
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